Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) CFO Sells 977 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) CFO Jeffrey V. Poulton sold 977 shares of the business’s stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $194.59, for a total value of $190,114.43. Following the completion of the transaction, the chief financial officer now owns 11,706 shares […]

Related Keywords

Thomas Tuschl ,Phillip Zamore ,Jeffreyv Poulton ,David Bartel ,Group Ltd ,Sg Americas Securities ,Fosun International Ltd ,Canaccord Genuity Group ,Jpmorgan Chase Co ,Alnylam Pharmaceuticals Company Profile ,Quarter For Alnylam Pharmaceuticals ,Institutional Investors Weigh In On Alnylam Pharmaceuticals ,Citigroup ,Alnylam Pharmaceuticals ,Nasdaq ,Alnylam Pharmaceuticals Inc ,Alnylam Pharmaceuticals Stock ,News Ratings For Alnylam Pharmaceuticals Daily ,Wealthfront Advisers ,Get Rating ,Genuity Group ,Noble Laureate ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Insider Trading ,Nsider Trades ,Stocks ,